{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:41:59Z","timestamp":1772664119726,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.atherosclerosis.2006.11.012","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T07:21:59Z","timestamp":1165994519000},"page":"365-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction"],"prefix":"10.1016","volume":"196","author":[{"given":"Alberto","family":"Dominguez-Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn J.","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2362.2002.00980.x","article-title":"Emerging role of metalloproteinases in the pathophysiology of cardiac diseases","volume":"32","author":"Diez","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/01.CIR.101.15.1833","article-title":"Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart","volume":"101","author":"Cheung","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.103.17.2181","article-title":"Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia\/reperfusion","volume":"103","author":"Lindsey","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0735-1097(98)00250-2","article-title":"Peripheral blood levels of matrix metalloproteases-2 and \u22129 are elevated in patients with acute coronary syndromes","volume":"32","author":"Kai","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.112238","article-title":"Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome","volume":"141","author":"Inokubo","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diab.23.2.105","article-title":"Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study","volume":"23","author":"Garcia","year":"1974","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.164.13.1457","article-title":"Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events","volume":"164","author":"Franklin","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.ATV.0000054195.35121.5E","article-title":"Antidiabetic PPAP gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease","volume":"23","author":"Marx","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib10","doi-asserted-by":"crossref","unstructured":"Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardilogy Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959\u201369.","DOI":"10.1016\/S0735-1097(00)00804-4"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients","volume":"20","author":"Killip","year":"1967","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0735-1097(83)80200-9","article-title":"Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population","volume":"1","author":"Wahr","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(00)02640-4","article-title":"Cardiogenic shock complicating acute coronary syndromes","volume":"356","author":"Hasdai","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0009-8981(94)90256-9","article-title":"A one-step sandwich enzyme immunoassay for the inactive precursor and complexes forms of human matrix metalloprotease 9 (92kDa gelatinase\/type IV collagenase, gelatinase B) using monoclonal antibodies","volume":"231","author":"Fujimoto","year":"1994","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib15","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib16","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Screening for type 2 diabetes: Diabetes Care 2004;(Suppl. 1):S11\u2013S14.","DOI":"10.2337\/diacare.27.2007.S11"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0735-1097(99)00508-2","article-title":"Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction","volume":"35","author":"Hasdai","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib18","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib19","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1001\/jama.1988.03410230074031","article-title":"The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study","volume":"260","author":"Abbott","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.1711660308","article-title":"Human coronary microvessels in diabetes and in ischaemia. Morphometric study of autopsy material","volume":"166","author":"Yarom","year":"1992","journal-title":"J Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2006.11.012_bib21","first-page":"II27","article-title":"Endothelial function: a critical determinant in atherosclerosis?","volume":"109","author":"Landmesser","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0735-1097(89)90053-3","article-title":"The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group","volume":"14","author":"Stone","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib23","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8227(88)80016-0","article-title":"Asymptomatic diabetic cardiomyopathy: a noninvasive study","volume":"4","author":"Attali","year":"1988","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0002-9343(89)80691-6","article-title":"Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old","volume":"87","author":"Bouchard","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0140-6736(00)04151-9","article-title":"Matrix metalloproteinases in pathophysiology and treatment of heart failure","volume":"357","author":"Feldman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1152\/ajpcell.2001.280.1.C53","article-title":"Oxidative stress regulates collagen s\u00edntesis and matriz metalloproteinase activity in cardiac fibroblasts","volume":"280","author":"Siwik","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1054\/jcaf.2002.129659","article-title":"Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure","volume":"8","author":"Wilson","year":"2001","journal-title":"J Card Fail"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0021-9150(91)90235-U","article-title":"Atherosclerotic plaque caps are locally weakened when macrophage density is increased","volume":"87","author":"Lendon","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(03)00140-0","article-title":"High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes","volume":"168","author":"Death","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib31","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.2337\/diabetes.51.10.3063","article-title":"Evidence for a matrix metalloproteinase induction\/activation system in arterial vasculature and decreased synthesis and activity in diabetes","volume":"51","author":"Portik-Dobos","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib32","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2337\/diacare.27.8.2049","article-title":"Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy","volume":"27","author":"Tayebjee","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2006.11.012_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hh1501.094396","article-title":"Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?","volume":"89","author":"Creemers","year":"2001","journal-title":"Circ Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:30:41Z","timestamp":1758155441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006006885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0021915006006885"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.012","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}